Osler Diagnostics was spun out of the of the Chemistry Department at the University of Oxford in February 2016 to develop portable point-of-care (PoC) diagnostic platforms using novel electrochemical impedance-based sensing technology.
Osler’s method enables the detection of a panel of disease biomarkers in a portable device from a single drop of blood and will be applicable to most biomarkers. The Company plans to develop a range of products for the research and
diagnostics markets. Osler has developed a fully-functioning minimum viable product (MVP).